Immunome drops on stock offering

Immunome

29/01/2025 21:53

** Shares of Immunome Inc  IMNM.O  down 10.2% to $8.40
post-market as biotech firm looks to raise equity
** Bothell, Washington-based oncology specialist commences $125
mln stock offering
    ** Co intends to use net proceeds to fund clinical and
preclinical development of pipeline assets, and general
purposes, per the SEC filing
    ** JP Morgan, TD Cowen, Leerink and Guggenheim are jt
bookrunners
    ** With ~62.4  mln shares outstanding, IMNM has ~$583 mln
market cap, per LSEG data
    ** Shares closed up 1.2% at $9.35 on Weds. Still, stock has
lost 12% YTD and about 50% over the past 12 months
     

(Lance Tupper is a Reuters market analyst. The views expressed
are his own)
((lance.tupper@tr.com 1-646-279-6380))